8 Million Doses of Vaccine Bulk Arrive in Indonesia

INDUSTRY.co.id - On Tuesday (25/5), eight million doses of Sinovac vaccine bulk arrived in Indonesia. With the arrival of the thirteenth batch, Indonesia now has 83.9 million doses of COVID-19 vaccines in total.

“Previously, we have also received 3 million doses of ready-to-use vaccine from Sinovac, 6.4 million doses from AstraZeneca, and one million doses from Sinopharm.” Chairperson of the COVID-19 Handling and National Economic Recovery Committee Airlangga Hartarto said.

He went on to say that the vaccine arrival is an implementation of the Government’s efforts in securing COVID-19 vaccine supply for the national vaccination program so that Indonesia will immediately achieve herd immunity.

“The Government will always maintain the availability of the vaccines so they can be used to vaccinate target population,” he said adding that to achieve herd immunity, the Government has set a target to vaccinate 181.5 million people or 70 percent of its population.

Airlangga also ensured the public that the Government always takes into account the aspects of safety, quality, and efficacy before rolling out the vaccines.

“Thus, you should not worry to get vaccinated. The vaccines provided by the Government have been evaluated by the Indonesian Food and Drug Monitoring Agency (BPOM) and have obtained recommendations from the experts, the Indonesian Technical Advisory Group on Immunization (ITAGI), and the World Health Organization (WHO),” he explained.

On that occasion, he also told the public that the Government is speeding up the vaccination and calling on all people to get vaccinated. In addition, the public is also reminded to maintain discipline in adhering to health protocols.

“We must be aware that the pandemic, the COVID-19 is still raging. Besides vaccines, we also need to be discipline in wearing face masks, maintaining safe distance, and washing hands. That will be the keys for the success of the national vaccination program. In addition, the Government continues to intensify testing, tracing, and treatment measures,” he concluded.